SCHEMBL4948249

SCHEMBL4948249

COc1ccc(-c2nnc(O)n2-c2ccc(-c3ccccc3)cc2NC(C)=O)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 2/20 0.46
ABCB1 P08183 2/20 0.46
FYN P06241 1/20 0.44
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
KDM4E B2RXH2 3/20 0.43
HDAC1 Q13547 2/20 0.43
APOBEC3A P31941 1/20 0.43
GFER P55789 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
ADORA3 P0DMS8 1/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HDAC2 Q92769 2/20 0.40
HDAC3 O15379 1/20 0.40
PTK2 Q05397 1/20 0.40
PKM P14618 1/20 0.39
ALDH1A1 P00352 4/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4940524 0.92 FYN (0.44) ABCC1ABCB1FYNHSD17B1HSD17B2
SCHEMBL4936564 0.75 ALDH1A1 (0.43) KDM4EMAPTMEN1KMT2APKM
SCHEMBL4941844 0.74 KDM4E (0.46) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL4941855 0.73 PDE2A (0.42) KDM4EMAPTMEN1KMT2APKM
SCHEMBL4935329 0.73 PKM (0.56) KDM4EMAPTMEN1KMT2APKM
SCHEMBL4935290 0.73 HDAC1 (0.42) KDM4EHDAC1APOBEC3AGFERAPOBEC3G
SCHEMBL4948240 0.71 KMT2A (0.45) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL4940513 0.70 ALDH1A1 (0.56) KDM4EMAPTMEN1KMT2APKM
SCHEMBL17206120 0.69 HSD17B1 (0.55) HSD17B1HSD17B2KDM4EHDAC1APOBEC3A
SCHEMBL17206259 0.69 KDM4E (0.52) HSD17B1HSD17B2KDM4EHDAC1APOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182857-A1 Triazole Derivatives HSP90AB1, HSP90AA1, HSP90B1 ABCC1 59/4885ABCB1 35/4885FYN 3961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.